Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Downgrades Sunnova Energy Intl NYSENOVA with Lower Price Target

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Finances (2)
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

On February 23, 2024, analyst Donovan Schafer from Northland Capital Markets made a significant change to his outlook on Sunnova Energy Intl (NYSE:NOVA). Schafer downgraded the stock from Outperform to Market Perform and decreased the price target from $12 to $9. This decision was primarily driven by a Q4 revenue miss, prompting the revised price target.

Despite the downgrade, the consensus recommendation for NOVA remains bullish among 34 analysts, with an average stock forecast of $19.49. This suggests a potential upside of 64.22% from the current price.

NOVA Stock Price Plummets by 10.50% – What Investors Need to Know

On February 23, 2024, NOVA stock experienced a significant drop in its price performance. Trading near the bottom of its 52-week range and below its 200-day simple moving average, NOVA shares opened at $8.56, $0.01 lower than its previous close. Throughout the trading day, the price of NOVA shares decreased by $0.90, representing a 10.50% drop from the market’s last close.

Investors and analysts may be closely monitoring NOVA’s stock performance, as the significant decrease in price momentum could indicate potential challenges or concerns for the company. The stock’s position below its 200-day simple moving average suggests a downward trend in its price performance over a longer period.

It is important for investors to conduct thorough research and analysis before making any investment decisions, especially in light of the recent drop in NOVA’s stock price. Monitoring market trends, company news, and financial reports can provide valuable insights into the factors influencing a stock’s performance.

As always, it is advisable to consult with a financial advisor or investment professional to gain a better understanding of the implications of NOVA’s stock performance and to make informed decisions about investment strategies.

Revenue Up, Net Income Down – February 23, 2024 SEO Title

On February 23, 2024, NOVA stock experienced a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $720.65 million for the past year, which represented a 29.22% increase compared to the previous year. However, the total revenue remained flat since the last quarter at $194.18 million.

In terms of net income, NOVA reported a net loss of $417.96 million for the past year, which marked a significant decrease of 158.57% compared to the previous year. The net loss also decreased by 197.15% since the last quarter, coming in at -$187.64 million.

Furthermore, the earnings per share (EPS) for NOVA stock was reported at -$3.53 for the past year, reflecting a decrease of 150.07% compared to the previous year. The EPS also decreased by 190.19% since the last quarter, with a reported value of -$1.53.

Overall, NOVA stock showed a decline in net income and earnings per share compared to the previous year and last quarter. Despite the increase in total revenue compared to the previous year, the flat performance since the last quarter may have contributed to the mixed performance of NOVA stock on February 23, 2024. Investors and analysts will likely closely monitor the company’s financial performance in the coming quarters to assess its future prospects and potential for growth.

Tags: NOVA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare-sector

Guardant Health Inc Reports Strong FourthQuarter Sales and Optimistic Outlook for 2024

Analyst Initiates Coverage on ORIC Pharmaceuticals with Overweight Rating

Movanos Stock Surges as US Patent Application Nears Approval

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com